Breast Cancer Care: Research presented by Dr Azim at the seventh European Breast Cancer Conference
Friday, 26 March 2010
Statement from Breast Cancer Care on research presented by Dr Azim at the seventh European Breast Cancer Conference which suggests that pregnancy does not increase the risk of recurrence in women who have had breast cancer.
Maria Leadbeater, Clinical Nurse Specialist at Breast Cancer Care, said:
"To date there has been insufficient evidence on whether pregnancy following breast cancer treatment can increase a woman's risk of recurrence.
"While this research does not identify why pregnancy may reduce the risk of breast cancer returning, its suggestion that it will not lead to an increased risk will be very reassuring for younger women with breast cancer.
"Treatment for breast cancer can significantly reduce a woman's chance becoming pregnant, so it is vital that full information on fertility preserving treatments is given at the earliest possible stage."
For further media information, please contact
0207 960 3450/ 0770 290 1334
Disclaimer: Press releases published on this page are from key opinion formers
who promote their organisation's activities by subscribing to a campaign site within
politics.co.uk. politics.co.uk does not endorse, edit, or attempt to balance the
opinions expressed on this page. The content of press releases are wholly the responsibility
of the originating company or organisation.
Breast cancer cases 'on the increase'
Healthy living 'delays breast cancer'
Fears for future of breast cancer services
Over-50s 'unaware' of increased breast cancer risk
Trial launched to tackle breast cancer
HRT 'doubles risk of breast cancer'
Breast cancer screening saves live and is worth the cost, despite the health department’s findings.
New drugs cocktail gives hope to breast cancer sufferers
Fatty foods linked to breast cancer
Thousands of women will have access to a life-saving new drug on the NHS after the health watchdog today approved Herceptin for use against early stage breast cancer.